Kos Could Launch Icatibant For Hereditary Angioedema In 2007

The firm expects to report top-line data from two ongoing Phase III studies in the third quarter.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet